New Therapeutic Approved by FDA to Treat Prostate Cancer
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Tag: Prostate cancer
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55...
A team of mathematicians are designing an app that could help predict the likelihood of prostate cancer relapse.
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
Guest Post by Carlos S. Moreno, PhD Winship Cancer Institute of Emory University